BarrettKatzMDMBA
Ophthalmology • Cutchogue, NYNeuro-Ophthalmology
Emeritus Professor, Ophthalmology, Neurology and Neurosurgery, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY
Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Strohson Rd
Cutchogue, NY 11935Phone+1 646-831-3799
Education & Training
University of California San Francisco School of MedicinePost-Doctoral Fellowship, 1981 - 1982- University of California (San Francisco)Fellowship, Neuro-Ophthalmology, 1980 - 1981
Tufts Medical CenterResidency, Ophthalmology, 1978 - 1981
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1975 - 1978
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1975 - 1978
Clinical Center at the National Institutes of HealthFellowship, Neuro-Virology, 1974 - 1975
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1973 - 1974
Case Western Reserve University School of MedicineClass of 1973
Certifications & Licensure
AZ State Medical License 1981 - Present
CA State Medical License 1984 - Present
NY State Medical License 1974 - 2025
DC State Medical License 1999 - 2004- American Board of Ophthalmology Ophthalmology
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Academy of Neurology
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure Start of enrollment: 2007 Oct 01
- Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa Start of enrollment: 2018 Sep 26
- RESCUE and REVERSE Long-term Follow-up Start of enrollment: 2018 Jan 09
- Join now to see all
Publications & Presentations
PubMed
- 409 citationsA phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.Emmett T. Cunningham, Anthony P. Adamis, Michael M. Altaweel, Lloyd Paul Aiello, Neil M. Bressler
Ophthalmology. 2005-10-01 - 259 citationsHigh- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.Roy W. Beck, Jonathan D. Trobe, Pamela S. Moke, Robin L. Gal, Xing D
Archives of Ophthalmology. 2003-07-01 - 122 citationsBilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathyPatrick Yu-Wai-Man, Nancy J. Newman, Valerio Carelli, Mark L. Moster, Valérie Biousse
Science Translational Medicine. 2020-12-09
Press Mentions
Chutes & Ladders—GSK Vaccine Exec Reichman Splits to Take Biotech CEO PostJanuary 22nd, 2021- miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership TeamJanuary 19th, 2021
GenSight Biologics Appoints Magali Taiel as Chief Medical OfficerOctober 8th, 2019- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
